MPS IV

MPS IV

References in periodicals archive ?
Ocular manifestations in patients affected by Morquio syndrome (MPS IV).
Clinical findings in 12 patients with MPS IV A (Morquio's disease).
Bone mineral density in MPS IV A (Morquio syndrome type A).
Kinirons, "Clinical findings in 12 patients with MPS IV A (Morquio's disease).
In 2014 an 18-year-old girl with MPS IV, coming from the southeast of Italy, was referred to our Pediatric Pain Service for chronic low back pain and cephalalgia, both interfering with sleep and daily activities and partially responding to pain-relieving drugs.
[10] MPS patients (55 of III, MPS IV, MPS VI, whom agreed to participate) MPS type unknown Hendriksz Adult and pediatric Morquio A Syndrome et al.
The Morquio--Brailsford syndrome, known as mucopolysaccharidosis type IV (MPS IV), is listed as a "rare disease" by the Office of Rare Diseases of National Institutes of Health, with a prevalence of 1/ 200 000-250 000 people.
Cervical stenosis and spastic quadriparesis in Morquio disease (MPS IV).
Sin embargo, a diferencia de otras mucopolisacaridosis los pacientes con la MPS IV A no presentan compromiso de la esfera mental [7, 8, 2, 3].
(e) en las enfermedades producidas por la deficiencia de una sulfatasa (como MPS II, MPS III A, MPS III D, MPS IV A y MPS VI), la coexpresion con el factor activador de sulfatasas (SUMF1), involucrado en la activacion del sitio activo de todas las sulfatasas, ha permitido incrementos entre 2 y 3 veces en los valores de actividad de diferentes sulfatasas recombinantes, con un notable efecto en la distribucion de la enzima [21], la proporcion de la enzima secretada y las manifestaciones bioquimicas y clinicas de la enfermedad [22, 23].
MPS III, or Sanfilippo syndrome type A, B, C, and D, and MPS IV A, or Morquio syndrome type A, can present with Hurler-like symptoms, particularly in the early-onset variants.
Enzyme Disease P (a)/C Reference [alpha]-L-Iduronidase MPS I 13/7 2 (EC 3.2.1.76) Iduronate sulfatase MPS II 10/8 3 (EC 3.1.6.12) MSD 1/2 Arylsulfatase B MPS VI 10/8 4 (EC 3.1.6.1) MSD 1/2 [beta]-D-Glucuronidase MPS VII 2/1 5 (EC 3.2.1.31) [beta]-D-Galactosidase GM1 gangliosidosis 10/10 5 (EC 3.2.1.23) Galactosialidosis 1/1 MPS IV B NA [alpha]-D-Mannosidase [alpha]-Mannosidosis 2/2 5 (EC 3.2.1.24) [alpha]-L-Fucosidase Fucosidosis NA 5 (EC 3.2.1.51) [beta]-Hexosaminidase Sandhoff 3/3 5 (EC 3.2.1.30) Mucolipidosis II/III 5/4 (a) P, patients; C, carriers; NA, not available.